Literature DB >> 15647951

Thrombocytosis in preterm infants: a possible involvement of thrombopoietin receptor gene expression.

Hideki Nakayama1, Kenji Ihara, Shunji Hikino, Junko Yamamoto, Taro Nagatomo, Megumi Takemoto, Toshiro Hara.   

Abstract

Transient thrombocytosis is commonly observed in preterm infants after birth, but its physiological mechanism is still unknown. To understand the mechanism of the transient thrombocytosis in preterm infants we firstly evaluated a correlation between platelet counts and thrombopoietin (TPO) levels in preterm infants and next c-mpl mRNA levels on platelets in healthy preterm infants longitudinally during a half-year of life. The mean platelet counts in 45 very low birth weight infants (mean gestational age 27.4+/-1.8 weeks, mean birth weight 1047+/-249 g) was 230+/-71x10(9)/l just after birth and thereafter gradually increased to 579+/-178x10(9)/l by 5 weeks of age. The platelet counts continued this level for about next 8 weeks. Serum TPO levels soon after birth and at 1 month of age were significantly higher than those at the age of 2-6 months. There was a significant negative correlation between platelet counts and serum TPO values. The c-mpl expression levels on platelets at birth and at 1 month of age tended to be lower than those on platelets from adults, and the c-mpl levels gradually increased through 6 months of age, although they were still lower than those of adults. Our results suggest that low expression of TPO receptor on platelets until 1 month after birth cause a decreased TPO clearance and keep a high level of free TPO in blood, thereby promoting platelet production from megakaryocytes or their progenitors in bone marrow, resulting in the subsequent thrombocytosis in preterm infants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647951     DOI: 10.1007/s00109-004-0619-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  24 in total

1.  Circulating thrombopoietin levels in neonates with infection.

Authors:  P Colarizi; P Fiorucci; A Caradonna; F Ficuccilli; M Mancuso; P Papoff
Journal:  Acta Paediatr       Date:  1999-03       Impact factor: 2.299

2.  PLATELET COUNTS IN PREMATURE INFANTS.

Authors:  H S MEDOFF
Journal:  J Pediatr       Date:  1964-02       Impact factor: 4.406

3.  Developmental hematopoiesis in normal human fetal blood.

Authors:  F Forestier; F Daffos; N Catherine; M Renard; J P Andreux
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

Review 4.  Thrombopoietin.

Authors:  K Kaushansky
Journal:  N Engl J Med       Date:  1998-09-10       Impact factor: 91.245

5.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Authors:  D Ginsburg; B A Konkle; J C Gill; R R Montgomery; P L Bockenstedt; T A Johnson; A Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation.

Authors:  F Forestier; F Daffos; F Galactéros; J Bardakjian; M Rainaut; Y Beuzard
Journal:  Pediatr Res       Date:  1986-04       Impact factor: 3.756

7.  Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.

Authors:  H Donato; N Vain; P Rendo; N Vivas; L Prudent; M Larguía; J Digregorio; C Vecchiarelli; R Valverde; C García; P Subotovsky; C Solana; A Gorenstein
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

8.  Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit.

Authors:  M C Sola; D A Calhoun; A D Hutson; R D Christensen
Journal:  Br J Haematol       Date:  1999-01       Impact factor: 6.998

9.  The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults.

Authors:  Markus Schmugge; Margaret Lucille Rand; Kyong Won Annie Bang; Meera Mody; Michael Stephen Dunn; Kofi Sarpong Amankwah; Victor Stanley Blanchette; John Freedman
Journal:  Pediatr Res       Date:  2003-06-18       Impact factor: 3.756

10.  Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies.

Authors:  H Nishihira; Y Toyoda; H Miyazaki; H Kigasawa; E Ohsaki
Journal:  Br J Haematol       Date:  1996-01       Impact factor: 6.998

View more
  4 in total

1.  Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.

Authors:  Brian J Lannutti; Angela Epp; Jacqueline Roy; Junmei Chen; Neil C Josephson
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

2.  Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage.

Authors:  Brian W Whitcomb; Enrique F Schisterman; Mark A Klebanoff; Mona Baumgarten; Xiaoping Luo; Nasser Chegini
Journal:  Fertil Steril       Date:  2007-08-13       Impact factor: 7.329

3.  Asymptomatic late thrombocytosis is a common finding in very preterm infants even in the absence of erythropoietin treatment.

Authors:  Beatriz Del Rey Hurtado de Mendoza; Carla Balcells Esponera; Montserrat Izquierdo Renau; Isabel Iglesias Platas
Journal:  J Int Med Res       Date:  2019-02-08       Impact factor: 1.671

4.  Pathophysiology, classification, and complications of common asymptomatic thrombocytosis in newborn infants.

Authors:  Ga Won Jeon
Journal:  Clin Exp Pediatr       Date:  2021-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.